Literature DB >> 2147486

[Bone density after iatrogenic subclinical long-term thyrotoxicosis. Measurement by dual photon absorptiometry].

V Chabert-Orsini1, B Conte-Devolx, D Thiers-Bautrant, C Atlan-Gepner, A Denizot, J Audiffret, J F Henry, J L Codaccioni.   

Abstract

Thyrotoxicosis may be held responsible for osteoporosis. The question is whether a very slight subclinical hyperthyroidism, as is desirable in the post-operative treatment of differentiated thyroid carcinoma, can in the long run be detrimental to bone tissue. In a series of 37 patients, aged 50.9 +/- 11.1 years, presenting with the features of subclinical hyperthyroidism of 8.0 +/- 4.8 years duration, the authors have been unable to find any change in paraclinical parameters of bone and calcium-phosphate metabolism. Thirty-six of these 37 patients showed no abnormal decrease of vertebral bone density measured by dual photon absorptiometry.

Entities:  

Mesh:

Year:  1990        PMID: 2147486

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  2 in total

1.  Endogenous subclinical hyperthyroidism may not lead to bone loss in premenopausal women.

Authors:  T Saler; S Ahbab; Z A Sağlam; Ş Ö Keşkek; S Kurnaz
Journal:  Hippokratia       Date:  2014 Jul-Sep       Impact factor: 0.471

2.  Spinal bone mass after long-term treatment with L-thyroxine in postmenopausal women with thyroid cancer and chronic lymphocytic thyroiditis.

Authors:  F Hawkins; D Rigopoulou; K Papapietro; M B Lopez
Journal:  Calcif Tissue Int       Date:  1994-01       Impact factor: 4.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.